EU Urges Free Access To Publicly Funded COVID-19 Research Results
Set Of Principles Includes Online Publication And Technology Pooling
A “manifesto” to encourage the wider dissemination of COVID-19 research is the latest in a series of EU and international initiatives to quickly find treatments, vaccines and tests for the coronavirus.
You may also be interested in...
Almost three dozen countries have shown support for the alternative mechanism put forward by the World Health Organization to ensure that IP issues do not stand in the way of providing access to COVID-19 medicines, vaccines and diagnostics to ‘all of humanity.’
A resolution at the latest World Health Assembly meeting on providing universal and equitable access to COVID-19 technologies, medicines and vaccines has been adopted, along with an agreement to review the World Health Organization’s response to the crisis.
A new licensing route is to be introduced by the UK MHRA next year for products that meet specific criteria, such as treating life threatening conditions or rare diseases and where there is a significant patient need. At a webinar this week, an MHRA medical assessor looked at the requirements that products will have to meet to enter the new pathway.